According to I-Mab Biopharma's latest financial reports the company's current EPS (TTM) is 1,21ย โฌ. In 2021 the company made an earnings per share (EPS) of -4,23ย โฌ a decrease over its 2020 EPS that were of 1,09ย โฌ.